科赫勒斯生物科學CHRS
那斯達克 · USD
0.88
-0.06
(-6.64%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
科赫勒斯生物科學CHRS
0.88
-0.06
(-6.64%)
財務數據
損益表
- 0.45
- 0.32
- 0.59
- 0.75
- 0.92
- 0.77
- 1.40
- 0.71
- 0.54
- 0.08
- -0.16
- -28.48
- 81.02
- 27.00
- 22.74
- -15.80
- 81.32
- -49.35
- -23.50
- -85.97
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 7,599 | 54,144 | 70,774 | 139,734 | 77,063 | 91,524 | 74,568 | 58,716 | 32,436 | 45,352 |
營業成本 | 2,653 | 33,858 | 20,741 | 61,515 | 34,586 | 84,567 | 32,703 | 24,848 | 16,874 | 14,202 |
營業毛利 | 4,946 | 20,286 | 50,033 | 78,219 | 42,477 | 6,957 | 41,865 | 33,868 | 15,562 | 31,150 |
營業費用 | - | - | - | - | - | - | 73,871 | 68,411 | 83,307 | 82,643 |
研發費用 | 24,356 | 21,235 | 21,676 | 22,001 | 28,470 | 26,368 | 25,647 | 23,267 | 34,154 | 29,022 |
推銷及管理費用 | 26,025 | 41,297 | 34,744 | 51,465 | 56,532 | 49,494 | 48,224 | 45,144 | 49,153 | 53,621 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -45,435 | -42,246 | -6,387 | 4,753 | -42,525 | -68,905 | -32,006 | -34,543 | -67,745 | -51,493 |
其他收入及費用 | 187 | -3,104 | 998 | 166,569 | 156,516 | -129 | 2,253 | 1,617 | 1,728 | 2,008 |
利息費用 | 2,150 | 5,346 | 5,362 | 13,332 | 11,116 | 10,619 | 10,268 | 9,943 | 9,712 | 9,385 |
稅前純益 | -47,398 | -50,696 | -10,751 | 157,990 | 102,875 | -79,653 | -40,021 | -42,869 | -75,729 | -58,870 |
所得稅 | - | - | - | - | - | - | -380 | - | - | - |
稅後純益 | -56,569 | -50,696 | -10,751 | -12,921 | 102,875 | -79,653 | -39,641 | -42,869 | -75,729 | -58,870 |
基本每股稅後盈餘(元) | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 | -0.71 | -0.41 | -0.49 | -0.96 | -0.76 |
稀釋每股稅後盈餘(元) | -0.49 | -0.40 | -0.08 | -0.18 | 0.91 | -0.74 | -0.37 | -0.46 | -0.96 | -0.76 |
基本平均股數(千股) | 115857.00 | 115418.00 | 115210.00 | 114819.00 | 112749.00 | 111492.00 | 97738.00 | 87269.00 | 79268.00 | 77955.00 |
稀釋平均股數(千股) | 115857.00 | 115418.00 | 115210.00 | 114819.00 | 112749.00 | 111492.00 | 97738.00 | 87269.00 | 79268.00 | 77955.00 |
還原基本每股稅後盈餘(元) | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 | -0.71 | -0.41 | -0.49 | -0.96 | -0.76 |
還原稀釋每股稅後盈餘(元) | -0.49 | -0.40 | -0.08 | -0.18 | 0.91 | -0.74 | -0.37 | -0.46 | -0.96 | -0.76 |
還原基本平均股數(千股) | 115,857 | 115,418 | 115,210 | 114,819 | 112,749 | 111,492 | 97,738 | 87,269 | 79,268 | 77,955 |
還原稀釋平均股數(千股) | 115,857 | 115,418 | 115,210 | 114,819 | 112,749 | 111,492 | 97,738 | 87,269 | 79,268 | 77,955 |
EBITDA(千元) | -53,373 | -40,158 | -3,840 | 1,598 | 115,498 | -71,023 | -31,689 | -34,280 | -66,407 | -48,435 |